The U.S. Court of Appeals for the Fifth Circuit granted the Federal Drug Administration a partial stay in a late Wednesday night, unpublished opinion affecting the nationwide removal of an abortion pill from the market.

By a 2-1 vote, a three-judge panel permitted other aspects of a federal district court judge’s ruling to take effect that would block a seven-year effort by the FDA to widen access to the drug.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]